HSA — authorised 24 February 2014
- Marketing authorisation holder: AMYLIN PHARMS LLC
- Status: likely_approved
🇸🇬 Myalept in Singapore
HSA authorised Myalept on 24 February 2014
Marketing authorisation
Myalept in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Singapore
Frequently asked questions
Is Myalept approved in Singapore?
Yes. HSA authorised it on 24 February 2014.
Who is the marketing authorisation holder for Myalept in Singapore?
AMYLIN PHARMS LLC holds the Singaporean marketing authorisation.